Imugene agrees to link with Merck after share spike

MELBOURNE: Paul Hopper-chaired cancer fighter Imugene has inked a deal with Merck & ... read more

Biotech group finally calls in the administrators

SYDNEY: Flagship companies in the iQ Group, a controversial biotechnology operation that once ... read more

Lendlease sells retirement stake to Aware Super for $490

SYDNEY: Global developer and builder Lendlease has unveiled a deal that will see ... read more

Software issues send Sigma to a full-year loss

MELBOURNE: Demand for rapid antigen tests has cushioned the blow for Amcal Pharmacy ... read more